Project Grant R01NS134768

Award Date 7/6/24
Completion Date 4/30/29
Dollars Obligated $1.5M
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund research at the University of Colorado-Denver to investigate the role of synaptic adhesion molecules in guiding myelination of specific axons. The $429,000 grant, awarded from June 2025 to May 2027, will support the development of novel tools to visualize gene expression and protein localization related to axon-myelin interactions in living...
This federal Project Grant award of $614,009 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to understand the molecular mechanisms of oligodendrocyte myelination and remyelination. The primary goals are to identify critical factors that promote myelin production by oligodendrocytes and overcome inhibitory signals that impede myelination, in...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate how membrane-remodeling factors regulate oligodendroglial membrane dynamics and myelination in the central nervous system. The $458,189 award to the University of Texas Medical Branch at Galveston aims to: (1) identify membrane-binding factors expressed in...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA Program 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders, provides $576,142.00 to Oregon Health & Science University (OHSU) to conduct research on the molecular and genetic regulation of myelin capacity in the central nervous system (CNS). The key objectives are to: 1) Define the cellular mechanisms by which the FBXW7 protein regulates...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is providing $426,938 to Virginia Commonwealth University to explore the role of a novel glutamate-driven signaling pathway initiated in maturing oligodendrocytes through the glutamate transporter GLT-1/EAAT2. This research aims to characterize the mechanisms downstream of...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $454,424.00 to Kenyon College to characterize cellular and molecular mechanisms of Schwann cell demyelination and identify factors that promote peripheral remyelination. The goal is to develop a novel larval zebrafish model to visualize nerve damage and repair over time, in...
This federal Project Grant award, valued at $599,204.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the cellular mechanisms that drive learning-induced myelin remodeling and its role in motor learning. The key objectives are to: (1) determine whether calcium signaling is required for myelin sheath shortening...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $242,310 to Oregon Health & Science University to study the role of P/Q-type ion channels in the development of oligodendrocyte lineage cells, which are responsible for producing myelin in the central nervous system. The research aims to understand how disruptions in P/Q-type channels...
This $251,370 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to understand the role of the transcription factor BMAL1 in regulating oligodendrocyte precursor cell (OPC) differentiation and myelination. The research aims to characterize BMAL1's impact on OPC transcriptional regulation, evaluate methods to restore OPC...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $506,083.00 to Artificial Axon Labs Inc. to develop a novel biomimetic 3D-printed drug discovery platform called "Artificial Axons" for screening remyelinating compounds to treat multiple sclerosis (MS) and other myelin diseases. The key products and services...

MECHANISMS OF CNS MYELIN TARGETING - PROJECT ABSTRACT: EFFICIENT VERTEBRATE NERVOUS SYSTEMS REQUIRE THE PRECISE INSULATION OF CENTRAL NERVOUS SYSTEM (CNS) AXONS BY MYELINATING OLIGODENDROCYTES. HOWEVER, WE KNOW VERY LITTLE ABOUT HOW AXONS ARE SELECTED FOR MYELINATION AND WHY SOME CNS STRUCTURES ARE AVOIDED. WE SET OUT TO INVESTIGATE THESE QUESTIONS AND IDENTIFIED SEVERAL GENES, INCLUDING JUNCTION ADHESION MOLECULES 2 & 3 (JAMS 2 & 3) AND TRANSMEMBRANE PROTEIN 125B (TMEM125B) AS PUTATIVE REGULATORS OF CNS MYELIN TARGETING AND GROWTH. TMEM125B IS EXPRESSED IN MATURE, MYELINATING OLIGODENDROCYTES IN ZEBRAFISH, MICE, AND HUMANS WITH AN EXPRESSION PATTERN THAT IS CONSISTENT WITH ITS POSSIBLE ROLE IN MYELIN TARGETING AND MYELIN MAINTENANCE AND JAMS 2 & 3 ARE EXPRESSED IN NEURONS AND OLIGODENDROCYTE LINEAGE CELLS. IN OUR PRELIMINARY STUDIES, WE HAVE DISCOVERED THAT MUTATIONS OF TMEM125B AS WELL AS JAMS 2 & 3 CAUSE ECTOPIC MYELINATION OF CNS NEURONAL SOMA, CONSISTENT WITH A ROLE FOR THESE PROTEINS IN MYELIN TARGETING AND/OR GROWTH. IN THIS APPLICATION, WE WILL EXTEND THESE FINDINGS TO: 1) DETERMINE THE ROLE OF TMEM125B IN CNS MYELINATION (AIM 1), 2) CHARACTERIZE THE ROLE OF JAMS 2 & 3 IN DEVELOPMENTAL MYELINATION (AIM 2), AND 3) IDENTIFY THE BINDING PARTNERS FOR TMEM125B THAT INHIBIT ECTOPIC MYELINATION TO NEURONAL SOMA (AIM 3). WHEN COMPLETE, WE WILL HAVE A DEEPER UNDERSTANDING OF THE ROLE OF TMEM125B AND JAMS 2 & 3 IN CNS MYELINATION AS WELL AS INSIGHT INTO THE MECHANISMS THAT DRIVE APPROPRIATE MYELIN TARGETING DURING DEVELOPMENT.

Posted 7/6/24, 12:00 AM